Search
for

    Sort by

    Research 26

    1. 51223 A novel human disease model of alopecia areata to evaluate benefit of the DHODH inhibitor farudodstat Journal of the American Academy of Dermatology · 2024 · 1 citations
    2. 90 Exploring the therapeutic potential of DHODH inhibitor farudodstat for alopecia areata treatment in a novel ex vivo model of human hair follicle immune privilege collapse Journal of Investigative Dermatology · 2023 · 1 citations
    3. LB1777 A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment Journal of Investigative Dermatology · 2023 · 1 citations
    4. Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata Frontiers in Medicine · 2026
    5. Image 1_Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata.pdf Figshare · 2026
    6. ISIDLB1777 - A novel ex vivo model of human hair follicle immune privilege collapse reveals the potential of farudodstat, a DHODH inhibitor, as a therapeutic for alopecia areata treatment 2023
    7. Teriflunomide: a novel oral treatment for relapsing multiple sclerosis Expert Opinion on Pharmacotherapy · 2014 · 16 citations
    8. Teriflunomide (Aubagio®) for the treatment of multiple sclerosis Experimental Neurology · 2014 · 36 citations
    9. Olorofim Effectively Eradicates Dermatophytes <i>In Vitro</i> and <i>In Vivo</i> Antimicrobial Agents and Chemotherapy · 2021 · 7 citations
    10. Teriflunomide and Its Mechanism of Action in Multiple Sclerosis Drugs · 2014 · 253 citations
    11. “Nail loss after teriflunomide treatment: A new potential adverse event” Multiple Sclerosis and Related Disorders · 2017 · 6 citations
    12. Teriflunomide efficacy, safety and tolerability in patients with relapsing forms of multiple sclerosis Neurodegenerative disease management · 2013
    13. Teriflunomide in multiple sclerosis: an update Neurodegenerative disease management · 2016 · 20 citations
    14. Network pharmacology and in vivo experimental analysis for validating the antifibrotic potential of Punica granatum leaves against skin scleroderma: the role of oxidative stress, inflammation and TGF-β1/Snail 1/p-Smad 3 signaling pathway Inflammopharmacology · 2026
    15. Traditional Indian home remedies for minor ailments MGM Journal of Medical Sciences · 2024
    16. Therapeutics for COVID-19 and post COVID-19 complications: An update Current Research in Pharmacology and Drug Discovery · 2022 · 52 citations
    17. Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19 Microorganisms · 2022 · 8 citations
    18. Topical delivery of nanoemulsions for skin cancer treatment Applied Materials Today · 2023 · 34 citations
    19. Alopecia Areata: Pathogenesis, Diagnosis, and Therapies MedComm · 2025 · 21 citations
    20. Effects of SLC45A2 and GPNMB on Melanin Deposition Based on Transcriptome Sequencing in Chicken Feather Follicles Animals · 2023 · 10 citations
    21. An Overview of the Health Benefits, Extraction Methods and Improving the Properties of Pomegranate Antioxidants · 2023 · 41 citations
    22. Valorization of Punica granatum L. Leaves Extracts as a Source of Bioactive Molecules Pharmaceuticals · 2023 · 21 citations
    23. Improved Cardiovascular Effects of a Novel Pomegranate Byproduct Extract Obtained through Hydrodynamic Cavitation Nutrients · 2024 · 18 citations
    24. Hair Loss Associated with Teriflunomide Treatment Journal of Multiple Sclerosis and Neuroimmunology · 2023
    25. HPLC-ESI-MSn characterization of phenolic compounds, terpenoid saponins, and other minor compounds in Bituminaria bituminosa Industrial Crops and Products · 2015 · 76 citations
    26. Stability and efficacy of green solvent and natural excipient-based semisolid formulations compared with conventional formulations: a review Pharmacy Reports · 2026